Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...
News Medical on MSN10d
The emerging role of flavonoids in the treatment of type 2 diabetes mellitus: regulating the enteroendocrine systemType 2 diabetes mellitus (T2DM) is a prevalent yet complex metabolic disorder that has shown a rising incidence over the past few decades. Recent research has identified flavonoids as compounds ...
Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding ...
Hosted on MSN3mon
Revolutionary obesity and diabetes treatment burns energy and reduces appetite without side effectsPotential side effects include increased heart rates, hepatic glucose production, and loss of lean mass. Researchers have proposed combining GCGR agonists with insulinotropic agents, such as GLP-1 ...
It works by imitating the effects of certain hormones called incretins. Mounjaro is a type of drug called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP ...
Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...
Mounjaro, Eli Lilly's diabetes and obesity drug, is now available in India at a fraction of its US price. It offers treatment for weight loss and diabetes control, but watch out for the side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback